# Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines

> **NCT07239544** · — · ACTIVE_NOT_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 50 (estimated)

## Conditions studied

- Lung Cancer (NSCLC)

## Interventions

- **OTHER:** observational study

## Key facts

- **NCT ID:** NCT07239544
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2026-07-10
- **Final completion:** 2026-07-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07239544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07239544, "Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07239544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*